LongRiver Investments

We Have

Built Our Journey On a Foundation of Strong Support

Backed by leading global financial institutions and top-tier asset managers

One of the largest emerging venture capital vehicles in recent years

We Back

Future Sector Leaders With Global Resources

Driving innovation and growth in healthcare and technology

Capital, expertise, network

We Can

Manage the
Full Investment
Cycle-From
Sourcing to Exit

Source

Top-down research framework

Robust collaboration with industry leaders and KOLs

Invest

10+ years in Healthcare and Deep Tech

70+ Investments are globally distributed（Including pre-fund track record）

Scale

Cases from early stage to IPO

A full range of value-added services

Exit

Proven exit strategies with nearly 20 exits（Including pre-fund track record）

IPOs and M&A in global capital markets

We Believe

Three Things Matter Most

Accountability

We earn the trust of our LPs, stand with entrepreneurs, and keep ourselves accountable every step of the way.

Excellence

We keep doing the right thing - long term. We push to stay sharp and create value that lasts.

Entrepreneurship

We learn, adapt, and grow. We don’t chase trends - we build the edge that sets us apart.

News & Insights

LongRiver Portfolio company Ouro Medicines Enters into Definitive Agreement to be Acquired by Gilead Sciences

LongRiver portfolio company, Ouro Medicines, has entered into a definitive agreement to be acquired by Gilead Sciences.

24.03.2026

News & Insights